SCHEMBL741896

SCHEMBL741896

COc1ccc(C(C)(C)NC(=O)c2cc3c(NC(=O)c4cccs4)n[nH]c3s2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 7/20 0.47
NPC1 O15118 6/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
TP53 P04637 1/20 0.47
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
KDM4E B2RXH2 3/20 0.43
POLB P06746 2/20 0.42
PPARG P37231 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
NR2E3 Q9Y5X4 1/20 0.42
NCOR2 Q9Y618 1/20 0.42
TSHR P16473 1/20 0.42
MAPT P10636 5/20 0.42
CYP1A2 P05177 2/20 0.42
CYP3A4 P08684 2/20 0.42
CYP2C9 P11712 2/20 0.42
NPSR1 Q6W5P4 3/20 0.42
MAPK1 P28482 1/20 0.42
ABL1 P00519 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL739893 0.91 RAB9A (0.48) RAB9ANPC1SMN1; SMN2TP53MEN1
SCHEMBL743308 0.90 AURKA (0.48) RAB9ANPC1SMN1; SMN2MEN1KMT2A
SCHEMBL741356 0.89 KMT2A (0.43) RAB9ANPC1SMN1; SMN2MEN1KMT2A
SCHEMBL741609 0.87 AURKA (0.52) RAB9ANPC1SMN1; SMN2TP53MEN1
SCHEMBL739810 0.86 APLNR (0.47) RAB9ANPC1SMN1; SMN2TP53MEN1
SCHEMBL1779010 0.84 RXFP1 (0.48) RAB9ANPC1SMN1; SMN2MEN1KMT2A
SCHEMBL741526 0.84 RAB9A (0.41) RAB9ANPC1SMN1; SMN2MEN1KMT2A
SCHEMBL2412923 0.83 ALDH1A1 (0.64) RAB9ANPC1SMN1; SMN2TP53MEN1
SCHEMBL741622 0.83 RAB9A (0.41) RAB9ANPC1SMN1; SMN2MEN1KMT2A
SCHEMBL1779927 0.82 RXFP1 (0.49) RAB9ANPC1MEN1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US claimed
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US disclosed